For Research Use Only — Not for human or veterinary use.

Education

MOTS-C: Mitochondrial-Derived Peptide Research Overview

A research overview of the mitochondrial-encoded peptide MOTS-c, its proposed AMPK-linked mechanism, and the metabolic, exercise, bone, and aging research domains where it has been studied.

MOTS-C
All content on this page is for laboratory and academic reference only. This compound is supplied under a Research Use Only framework for in vitro and preclinical investigation by qualified personnel. Nothing on this page is clinical guidance, and it should not be interpreted as instructions for use in humans or animals.

Key Takeaways

  • MOTS-c is a 16-amino-acid peptide encoded within a short open reading frame inside the mitochondrial 12S rRNA gene, distinguishing it from nuclear-DNA-encoded proteins.[1]
  • Its proposed mechanism runs through inhibition of the folate cycle and de novo purine biosynthesis in skeletal muscle research models, leading to AICAR accumulation and AMPK activation.[2]
  • In mouse models, MOTS-c administration has been associated with reduced diet-induced obesity and improved insulin-sensitivity measures relative to controls.[1]
  • Under metabolic stress, MOTS-c has been reported to translocate to the nucleus and regulate antioxidant-response-element gene expression via interaction with NRF2.[3]
  • Skeletal muscle and circulating MOTS-c levels rise substantially after acute exercise in human study cohorts.[4]
  • Research models also describe MOTS-c involvement in osteoblast/osteoclast regulation and in aged mesenchymal stem cell models, extending its studied research domains beyond metabolism.[5][6]

What It Is

MOTS-c (an acronym for "Mitochondrial Open Reading Frame of the 12S rRNA type-c") is a 16-amino-acid peptide first identified by Lee and colleagues in 2015. What sets it apart structurally from most peptides studied in this catalog is its origin: MOTS-c is encoded not in nuclear DNA but within a short open reading frame nested inside the mitochondrial 12S ribosomal RNA gene.[1] This places it in a small class of molecules researchers term "mitochondrial-derived peptides" (MDPs) — regions of the mitochondrial genome historically assumed to be non-coding, but which produce bioactive peptides under study in specific research contexts.

Mechanism & Pathway

The mechanism proposed across MOTS-c research centers on AMPK (AMP-activated protein kinase), a cellular energy sensor that becomes active when a cell's energy reserves run low. In skeletal muscle research models, MOTS-c has been reported to inhibit the folate cycle and its linked de novo purine biosynthesis pathway. This inhibition causes an intermediate molecule called AICAR to accumulate, and AICAR is a known activator of AMPK.[2] Once AMPK is activated, downstream effects on glucose uptake and fat metabolism follow in the research models studied.

A separate line of research reported that under glucose-restriction stress, MOTS-c also translocates from the cytoplasm into the cell nucleus, where it was found to regulate a set of genes containing antioxidant response elements (ARE) — in part through interaction with the stress-responsive transcription factor NRF2.[3] This nuclear role is described in the literature as distinct from, and complementary to, the AMPK-linked pathway above.

Research Domains

  • Metabolic & insulin-sensitivity research — in diet-induced and age-induced obesity mouse models, MOTS-c administration was associated with reduced weight gain and improved insulin-sensitivity measures relative to controls.[1]
  • Exercise physiology research — human skeletal muscle biopsies showed MOTS-c protein levels increasing substantially following acute exercise bouts, with elevated levels persisting after a multi-hour rest period in some cohorts.[4]
  • Bone metabolism research — cell and animal models describe MOTS-c promoting osteoblast differentiation and mineralization while suppressing osteoclast activity, implicating it in bone-remodeling research.[5]
  • Cellular aging & senescence research — in aged human placenta-derived mesenchymal stem cell models, MOTS-c treatment was reported to promote markers of cellular homeostasis, a research angle relevant to in vitro aging models.[6]
  • Nuclear gene regulation research — under glucose-restriction stress conditions, MOTS-c was observed translocating to the nucleus and modulating antioxidant-response-element gene expression via NRF2 interaction.[3]

Comparative Notes

Mechanistically, MOTS-c is distinct from the receptor-agonist peptides elsewhere in this catalog. Compounds like R3 act on cell-surface GLP-1, GIP, and glucagon receptors to influence metabolic signaling from outside the cell. MOTS-c instead originates inside the mitochondria and is studied for both a cytoplasmic AMPK-linked pathway and a separate nuclear gene-regulation role — placing it, mechanistically, closer to a cellular energy-sensing signal than to a receptor-binding hormone analog.

MOTS-C product page →

Certificate of Analysis: What to Look For

A Certificate of Analysis for a MOTS-c research vial should report, at minimum: confirmed amino acid sequence (typically via mass spectrometry) and net peptide content. Because MOTS-c is a relatively short 16-residue peptide, mass spec confirmation of exact molecular weight is a useful cross-check against the expected sequence. Vials should be stored lyophilized at -20°C, protected from light, consistent with handling guidance for the other lyophilized peptides in this catalog.

References

  1. Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, Kim SJ, Mehta H, Hevener AL, de Cabo R, Cohen P (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. PMID: 25738459
  2. Lee C, Kim KH, Cohen P (2016). MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radical Biology and Medicine. PMID: 27216708
  3. Kim KH, Son JM, Benayoun BA, Lee C (2018). The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metabolism. PMID: 29983246
  4. Yoon TK, Lee CH, Kwon O, Kim MS (2022). Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c). Diabetes & Metabolism Journal. PMID: 35656563
  5. Yi X, Hu G, Yang Y, Li J, Jin J, Chang B (2023). Role of MOTS-c in the regulation of bone metabolism. Frontiers in Physiology. PMID: 37200834
  6. Yu WD, Kim YJ, Cho MJ, Seok J, Kim GJ, Lee CH, Ko JJ, Kim YS, Lee JH (2021). The mitochondrial-derived peptide MOTS-c promotes homeostasis in aged human placenta-derived mesenchymal stem cells in vitro. Mitochondrion. PMID: 33639272

FAQ

MOTS-c is encoded within a short open reading frame located inside the mitochondrial 12S rRNA gene, rather than within nuclear DNA, which places it among a class of molecules known as mitochondrial-derived peptides.[1]

The majority of published mechanistic research centers on AMPK activation via folate-cycle inhibition and AICAR accumulation in skeletal muscle models, alongside a separate nuclear gene-regulation role reported under metabolic stress conditions.[2][3]

Yes. Multiple human studies have measured MOTS-c levels in skeletal muscle and circulation before and after exercise, reporting substantial increases following acute exercise bouts.[4]

No — published research models also examine MOTS-c in bone-metabolism and cellular-aging contexts, in addition to the metabolic and exercise-physiology literature it is most associated with.[5][6]

A COA for a MOTS-c research vial should report confirmed amino acid sequence and net peptide content, with mass spectrometry confirmation of molecular weight recommended given the peptide's short 16-residue length.

No. MOTS-c is supplied strictly under a Research Use Only framework for laboratory and preclinical investigation, and none of the studies referenced here involve clinical administration guidance.

Related Guides